Author:
Radomski Shannon N.,Ali Sundas,Lafaro Kelly J.,Shubert Christopher,Hidalgo Madison,Chung Haniee,Christenson Eric S.
Reference6 articles.
1. ctDNA as a prognostic biomarker in resectable CLM: systematic review and meta-analysis;Wang;Open Life Sci,2023
2. The role of biomarkers in the management of colorectal liver metastases;Hewitt;Cancers,2022
3. Postoperative circulating tumor DNA testing based on tumor naïve strategy after liver metastasis surgery in colorectal cancer patients;Jiang;Front Oncol,2023
4. Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study;Tie;PLOS Med,2021
5. Circulating tumor DNA: towards more individualized treatment for patients with resectable colorectal cancer;Adams;J Gastrointest Cancer,2023